Australia markets closed

Matinas BioPharma Holdings Inc (6LJ.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.1473+0.0041 (+2.86%)
As of 08:02AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,125
1,096
3,188
33
158.333
Operating expenses
Research development
17,051
14,489
16,678
14,583
14,359
Selling general and administrative
10,898
10,373
11,100
10,185
10,006
Total operating expenses
27,949
24,862
27,778
24,768
24,365
Operating income or loss
-25,824
-23,766
-24,590
-24,735
-24,207
Total other income/expenses net
1,762
824
3,593
1,452
1,760
Income before tax
-24,062
-22,942
-20,997
-23,283
-22,447
Income from continuing operations
-24,062
-22,942
-20,997
-23,283
-22,447
Net income
-24,062
-22,942
-20,997
-23,283
-22,447
Net income available to common shareholders
-24,062
-22,942
-20,997
-23,679
-23,240
Basic EPS
-0.10
-
-0.10
-0.11
-0.12
Diluted EPS
-0.10
-
-0.10
-0.11
-0.12
Basic average shares
217,166
-
216,811
210,178
196,895
Diluted average shares
217,166
-
216,811
210,178
196,895